Telix Pharmaceuticals agrees to acquire RLS USA for upto $250 million
MELBOURNE: Telix Pharmaceuticals Limited (ASX: TLX) has signed an agreement to acquire RLS (USA) Inc., from its parent company, RLS Group Ltd. The acquisition significantly...
Telix Pharmaceuticals launches IPO in United States
Melbourne: Telix Pharmaceuticals Limited (ASX: TLX) launched its initial public offering in the United States of AmericanDepositary Shares (ADSs), each representing one ordinary share in...
Telix Pharmaceuticals signs deal to acquire QSAM Biosciences for upto $123m
MELBOURNE, AUSTRALIA: Telix Pharmaceuticals Limited has entered into an agreement to acquire QSAM Biosciences, Inc. and its lead investigational drug Samarium-153-DOTMP (153Sm-DOTMP). The purchase price...